Mefigril-T 500 Tablet is a combination medication containing Tranexamic Acid 500 mg and Mefenamic Acid 250 mg, primarily indicated for the management of heavy menstrual bleeding and associated dysmenorrhea. Tranexamic Acid is an antifibrinolytic agent that works by inhibiting the activation of plasminogen to plasmin, thereby reducing the breakdown of fibrin clots and minimizing excessive bleeding. Mefenamic Acid is a nonsteroidal anti-inflammatory drug (NSAID) that provides analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes, resulting in decreased prostaglandin synthesis. This dual-action formulation effectively controls excessive menstrual blood loss while alleviating pain and inflammation associated with menstruation. Mefigril-T 500 is typically prescribed for women experiencing menorrhagia and painful periods, offering symptomatic relief and improved quality of life. It is important to use this medication under medical supervision, considering contraindications such as hypersensitivity to NSAIDs, active thromboembolic disorders, or history of gastrointestinal ulcers. Common adverse effects may include gastrointestinal discomfort, nausea, or hypersensitivity reactions. Patients should adhere to the prescribed dosage and report any unusual symptoms to their healthcare provider. Mefigril-T 500 Tablet represents a targeted therapeutic option for managing menstrual disorders involving both bleeding and pain components.